drugset / Trial / NCT00593255
Efficacy and Safety of Insulin Aspart in Subjects With Type 1 or Type 2 Diabetes
RandomizedParallel-groupOpen-labelTreatment
Summary
This trial is conducted in Asia. The aim of this trial is to compare the efficacy of postprandial plasma glucose of two treatment regimens in Chinese subjects.
Timeline
- Start
- 2004-07
- Primary completion
- 2005-04
- Completion
- 2005-04
Publications
- Results Gao Y, Pan C, Zou D, Xu Z, Liu X, Guo X. Superior prandial glucose control with Insulin Aspart compared to Regular Human Insulin in Basal Bolus Therapy with NPH in Patients with Inadequately Controlled T1DM or T2DM. ADA 2006 2006; 55 (Suppl. 1): A464 (2005-PO)
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | insulin aspart | Protein / enzyme biologic | — | — |
| Subject | soluble human insulin | Unknown | — | — |
| Background | insulin NPH | Protein / enzyme biologic | — | — |